Profile
| Metric | Value |
|---|---|
| Full Name | Celcuity Inc. |
| Ticker | NASDAQ: CELC |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | celcuity.com |
| Employees | 87 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $109.17 | |
| Price, 1D Change | +3.95% | |
| Market Cap | $5B | |
| - | ||
| PE Ratio | - | |
| Beta | 1.07 | |
| Revenue | $0 | |
| Revenue, 1Y Change | 0.00% | |
| EPS | -$2.83 | |
| EPS, 1Y Change | -5.20% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | -$2.83 | |
| EPS Estimate | -$3.67 | |
| EPS Est. Change | -29.52% | |
| Revenue | $0.00 | |
| Revenue Estimate | - | |
| Revenue Est. Change | - | |
| Current Price | $109.17 | |
| Price Target | - | $110.00 |
| Price Tgt. Change | - | +0.76% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$2.78 | -$2.69 | +3.12% | |
| -$2.49 | -$2.83 | -13.80% | |
| -$3.67 | N/A | -29.52% | |
| -$4.52 | N/A | -59.40% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| $40.93M | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | +721.44% | |
| Price, 3Y | +807.48% | |
| Market Cap, 1Y | +923.32% | |
| Market Cap, 3Y | +1,837.96% | |
| Revenue, 1Y | 0.00% | |
| Revenue, 3Y | 0.00% | |
| EPS, 1Y | -5.20% | |
| EPS, 3Y | -28.09% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $109.17 | |
| SMA 200 | $44.90 | |
| SMA 200 vs Price | -58.88% | |
| SMA 50 | $93.93 | |
| SMA 50 vs Price | -13.96% | |
| Beta | 1.07 | |
| ATR | $4.49 | |
| 14-Day RSI | 71.01 | |
| 10-Day Volatility | 27.35% | |
| 1-Year Volatility | 182.11% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| Dividends Paid | $0.00 | |
| Payout Ratio | 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $0.00 | |
| EPS | -$2.83 | |
| Gross Profit | -$129.90K | |
| - | ||
| Operating Profit | -$113.27M | |
| - | ||
| Net Income | -$111.78M | |
| - | ||
| EBITDA | -$101.37M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 0.85 | |
| Current Ratio | 7.71 | |
| Quick Ratio | 7.71 | |
| - | ||
| - | ||
| Altman Z-Score | 21.53 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | - | |
| PS Ratio | - | |
| PB Ratio | 43.19 | |
| EV/EBITDA | -30.87 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $115.62M | |
| Cash & Equivalents | $22.51M | |
| Total Assets | $245.12M | |
| Current Assets | $244.57M | |
| Total Liabilities | $129.50M | |
| Current Liabilities | $31.72M | |
| Total Debt | $97.95M | |
| Short Term Debt | $172.00K | |
| Accounts Payable | $9.37M |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $113.27M | |
| Operating Expenses | $113.27M | |
| Cost Of Goods Sold | $129.90K | |
| SG&A | $9.06M | |
| D&A | $129.90K | |
| Interest Expense | $0.00 | |
| Income Tax | $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | -$83.47M | |
| CFI | -$63.07M | |
| CFF | $138.39M | |
| Capex | $249.90K | |
| Free Cash Flow | -$83.72M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Wells Fargo | ||
| Jefferies | → | |
| Wolfe Research | ||
| HC Wainwright & Co. | → | |
| Stifel | → | |
| Craig-Hallum | → | |
| HC Wainwright & Co. | → | |
| Needham | → | |
| Needham | → | |
| Guggenheim |
Analyst sentiment
Institutional ownership
Screeners with CELC
Data Sources & References
- CELC Official Website www.celcuity.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1603454/000149315225022401/0001493152-25-022401-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1603454/000164117225001826/0001641172-25-001826-index.htm
- CELC Profile on Yahoo Finance finance.yahoo.com/quote/CELC
- CELC Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/celc
FAQ
What is the ticker symbol for Celcuity Inc.?
The ticker symbol for Celcuity Inc. is NASDAQ:CELC
Does Celcuity Inc. pay dividends?
No, Celcuity Inc. does not pay dividends
What sector is Celcuity Inc. in?
Celcuity Inc. is in the Healthcare sector
What industry is Celcuity Inc. in?
Celcuity Inc. is in the Biotechnology industry
What country is Celcuity Inc. based in?
Celcuity Inc. is headquartered in United States
When did Celcuity Inc. go public?
Celcuity Inc. initial public offering (IPO) was on September 20, 2017
Is Celcuity Inc. in the S&P 500?
No, Celcuity Inc. is not included in the S&P 500 index
Is Celcuity Inc. in the NASDAQ 100?
No, Celcuity Inc. is not included in the NASDAQ 100 index
Is Celcuity Inc. in the Dow Jones?
No, Celcuity Inc. is not included in the Dow Jones index
When was Celcuity Inc. last earnings report?
Celcuity Inc.'s most recent earnings report was on November 12, 2025
When does Celcuity Inc. report earnings?
The next expected earnings date for Celcuity Inc. is March 30, 2026